Company intelligence / Profile preview

Pinpoint Scientific

Leeds, United Kingdom

Ownership: Private
Employees: ~35
Development stage: Other

Overview

AI-powered blood test for early cancer detection using machine learning on clinical data; real-world NHS evaluation completed Summer 2025 for five cancer pathways including Lower GI cancers.

Therapeutic areas: Oncology
Industry: Molecular Diagnostics

Partnerships

NHS EnglandSBRI HealthcareUniversity of Leeds

Beyond the preview

Go deeper on Pinpoint Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pinpoint Scientific.

Explore the full profile